Financials

  • Market Capitalization 779.14 M
  • Employee 61
  • Founded 2006
  • CEO N/A
  • Website www.zevra.com
  • Headquarter Delaware, United States
  • FIGI BBG0026ZG1F5
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
6.64
Rapporto prezzo/fatturato
4.82

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2592
IVA
Inventiva S.A. - American Depository Shares
4.30 USD0.00%+11.11%+11.69%+28.74%830.92 M USD
2609
CTMX
CytomX Therapeutics, Inc. - Common Stock
3.70 USD-1.60%-3.90%+21.31%+56.12%805.50 M USD
2640
SPRY
ARS Pharmaceuticals, Inc. - Common Stock
7.74 USD-2.52%-8.40%-21.42%-15.96%768.61 M USD
2642
RIGL
Rigel Pharmaceuticals, Inc. - Common Stock
41.30 USD-2.94%+1.57%+24.25%+37.07%764.14 M USD

Notizie